CalciMedica, Inc.CALCNASDAQ
Loading
SG&A Expense Growth Recovery in ProgressRecovering
Percentile Rank29
Studio
Year-over-Year Change

Year-over-year SG&A expense growth

Percentile
P29
Within normal range
vs 5Y Ago
-0.6x
Contraction
Streak
1 yr
Consecutive growthRecovering
PeriodValue
2025-18.91%
2024-56.22%
2023280.22%
2022-65.72%
202192.15%
202034.01%
201918.22%
20180.00%